Icon (ICLR) and Mural Health, a clinical trial technology company, announced a partnership to utilize Mural’s participant management and ...
"From our very first conversations with ICON, we were highly impressed by their commitment to patient care and innovation," said Sam Whitaker, CEO of Mural Health. "This partnership represents a ...
The company is seeing strong demand from recent strategic alliances and has several partnership opportunities beyond the top 20 pharma cohort. Icon PLC (NASDAQ:ICLR) is investing in digital ...